𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Does serum levels of regulators of angiogenesis predict poorer survival in patients with head and neck squamous cell carcinoma?

✍ Scribed by Michaelina Macluskey; H. Alkhadar; S. Jones; P. McLoughlin

Book ID
116316946
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
59 KB
Volume
46
Category
Article
ISSN
0266-4356

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Using TNM staging to predict survival in
Using TNM staging to predict survival in patients with squamous cell carcinoma of head & neck
✍ Stephen F. Hall; Patti A. Groome; Deanna Rothwell; Peter F. Dixon πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 95 KB πŸ‘ 3 views

## Background: There is a need for a classification system for prognosis based on the tnm system for patients with squamous cell carcinoma of the head and neck such that patient groupings are homogeneous within and heterogeneous between. ## Methods: Six hundred fifty-five consecutive patients wit

A pilot study of longitudinal serum cyto
A pilot study of longitudinal serum cytokine and angiogenesis factor levels as markers of therapeutic response and survival in patients with head and neck squamous cell carcinoma
✍ Colleen H. Druzgal; Zhong Chen; Ning T. Yeh; Giovana R. Thomas; Frank G. Ondrey; πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 245 KB πŸ‘ 2 views

## Background: Head and neck squamous cell carcinomas (hnsccs) were previously shown to express a repertoire of cytokines and angiogenesis factors that contribute to malignant pathogenesis and are detectable in serum. pretreatment and posttreatment serum levels of cytokines and angiogenesis factors

High serum levels of YKL-40 in patients
High serum levels of YKL-40 in patients with squamous cell carcinoma of the head and neck are associated with short survival
✍ Anne Roslind; Julia S. Johansen; Ib J. Christensen; Katalin Kiss; Eva Balslev; D πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 273 KB πŸ‘ 2 views

## Abstract YKL‐40 is a glycoprotein secreted by macrophages, neutrophils and malignant tumor cells. Elevated serum levels of YKL‐40 are associated with poor prognosis in several malignancies. In this study, we examined the prognostic value of serum YKL‐40 before treatment and during follow‐up in p